If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Notice of Results

17 Mar 2014 07:00

RNS Number : 4052C
Allergy Therapeutics PLC
17 March 2014
 



17 March 2014

 

 

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

 

Notice of results

 

Allergy Therapeutics plc (AIM: "AGY" or the "Company"), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, will announce its Interim Results for the six months ended 31 December 2013 on Monday 24 March 2014.

 

- Ends -

 

For further information

 

Allergy Therapeutics

+44 (0) 1903 845 820

Manuel Llobet, Chief Executive Officer

Ian Postlethwaite Finance Director

 

 

 

FTI Consulting

 

Simon Conway / Victoria Foster-Mitchell

+44 (0) 20 3727 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORGMGMFRDNGDZM

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS